Symbols

XYLO(Delisted)

Xylo Technologies·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 0

Price Hits New High

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About XYLO

Xylo Technologies Ltd.

A technology solution provider providing customized IT consulting and technical services for the healthcare industry

Industry

Established Date

12/09/1999

Listing Date

08/05/2015

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.medigus.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

10 Hanechoshet, 4th Floor, Tel-Aviv 6971072, Israel

Business

Introduction

Xylo Technologies Ltd., was incorporated in Israel on December 9, 1999. The Company is a medical device company engaged in the development, manufacture and marketing of surgical endoscopes and direct vision systems for minimally invasive medical procedures or other commercial uses. Their expertise is in the development, production and sale of innovative surgical devices with direct visualization for the treatment of gastroesophageal reflux disease, or GERD, a common disease that is primarily treated with medication (such as proton pump inhibitors) or chronic cases, routine open or laparoscopic surgery.

Company Financials

EPS

XYLO has released its 2022 Q2 earnings. EPS was reported at -0.15, versus the expected 0, missing expectations. The chart below visualizes how XYLO has performed over recent quarters, highlighting trends in earnings surprises.